New insider Ticktin Robert claimed ownership of 106,318 shares (SEC Form 3)
$PMVP
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/21/2025 |
3. Issuer Name and Ticker or Trading Symbol
PMV Pharmaceuticals, Inc. [ PMVP ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 106,318(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (right to buy) | (2) | 06/02/2030 | Common Stock | 1,449 | $4.22 | D | |
| Employee Stock Option (right to buy) | (2) | 08/28/2030 | Common Stock | 102,460 | $8.53 | D | |
| Employee Stock Option (right to buy) | (3) | 01/18/2034 | Common Stock | 168,820 | $1.8 | D | |
| Employee Stock Option (right to buy) | (4) | 08/13/2034 | Common Stock | 196,379 | $1.48 | D | |
| Employee Stock Option (right to buy) | (5) | 03/03/2035 | Common Stock | 265,000 | $1.32 | D | |
| Explanation of Responses: |
| 1. Includes 79,150 shares represented by restricted stock units, or RSUs, all of which vest on June 30, 2025. |
| 2. Shares subject to the option are fully vested and immediately exercisable. |
| 3. Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024. |
| 4. One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter. |
| 5. Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025. |
| Remarks: |
| Exhibit 24.1 - Power of Attorney |
| /s/ Robert Ticktin | 04/23/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||